Breaking News

Körber Wins Bioprocessing Excellence Award for Werum PAS-X

Recognizes Werum PAS-X software products facilitate biomanufacturing excellence at enhanced speed, reduced cost and superior quality.

By: Kristin Brooks

Managing Editor, Contract Pharma

Körber, a provider of Manufacturing Execution Systems (MES) for the pharma, biotech and cell & gene therapy industries, is honored for its Werum PAS-X software products with the Europe Bioprocessing Excellence Award 2021 in the category “Best Bioprocessing Supplier Award: Software.”
 
The award recognizes Körber as industry leader in the bioprocessing scene, facilitating biomanufacturing excellence at enhanced speed, reduced cost and superior quality all across Europe and the rest of the world.
 
Körber received the Europe Bioprocessing Excellence Award for its Werum PAS-X MES Suite, which is recognized as the world’s leading Manufacturing Execution System for the pharma, biotech and cell & gene industries. While the number of cell therapy products in late stages of clinical trials is rapidly growing, electronic systems are emerging as the only option for managing large patient volumes. Through digitized and automated processes, PAS-X MES is ideally suited to target these challenges for cell & gene therapy manufacturers.
 
Werum PAS-X MES is supplemented by innovative data science software: Werum PAS-X Savvy is designed to help accelerate biopharmaceutical processes and connects people across departments and sites. With PAS-X Savvy bioprocess engineers and data scientists can manage, visualize and analyze bioprocess data fast, comprehensive and in real time.
 
“We are truly honored to receive this high industry recognition and to be named Best Bioprocessing Supplier for software,” said Dr. Christoph Fink, Chief Operating Officer (COO) Software at the Körber Business Area Pharma. “I would like to thank our customers and partners for their trust in us and our digital solutions. This award underlines that we truly understand what it takes to ensure manufacturing quality in scaling highly complex and variable manufacturing processes – e.g. in biotech and cell & gene. This motivates us to constantly improve the features of our products, share best practices and advisory in the growing community of our clients.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters